Vecuronium Bromide FDA Link Generic

Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.

Also Known As:

Vecuronium; NC 45; NC-45; Norcuron; ORG-NC 45; ORG-NC-45; ORG-NC45; Vecuronium Bromide, Quaternary Ion; Vecuronium Citrate; Vecuronium Hydrobromide; Vecuronium Hydrochloride; Vecuronium Maleate; Vecuronium Phosphate; Bromide, Vecuronium; Citrate, Vecuronium; Hydrobromide, Vecuronium; Hydrochloride, Vecuronium; Maleate, Vecuronium; NC45; ORG NC 45; ORG NC45; ORGNC 45; ORGNC45; Phosphate, Vecuronium; Piperidinium, 1- ((2beta,3alpha,5alpha,16beta,17beta)- 3,17- bis(acetyloxy)- 2- (1- piperidinyl)androstan- 16- yl)- 1- methyl- , bromide

Pharmalogical Action Categories:

Neuromuscular Nondepolarizing Agents
Nicotinic Antagonists

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Androstanes: 11
      - Androstanols
        Vecuronium Bromide: 639

Org 7684

Bio-Agent Context: Research Results